Cargando…
New Actions on Actionable Mutations in Lung Cancers
Autores principales: | Le, Xiuning, Elamin, Yasir Y., Zhang, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252025/ https://www.ncbi.nlm.nih.gov/pubmed/37296880 http://dx.doi.org/10.3390/cancers15112917 |
Ejemplares similares
-
MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities
por: Qin, Kang, et al.
Publicado: (2023) -
New Discovery of Curcumin Combination Therapy and Action Mechanism
por: Dai, Chongshan, et al.
Publicado: (2020) -
Behavioral Cardiology: Cardiology’s New Frontier of
Action
por: Katz, Marcelo, et al.
Publicado: (2015) -
Indoor Radon and Lung Cancer: National Radon Action Plans Are Urgently Required
por: Nam, Hae-Seong, et al.
Publicado: (2018) -
Management of brain metastases in non-small cell lung cancer without actionable driver mutations—the need to dive deeper in the right ‘pool’
por: Jablonska, Paola Anna, et al.
Publicado: (2023)